Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data offering renewed hope for patients.

Led by former Novartis executive Emanuele Ostuni, the startup has a prostate cancer medicine advancing into early clinical ...

University of Michigan researchers identified a gene program associated with extreme non-response to the cancer drug ...

I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.